IP Library Granted Patent US 12,146,141
Granted Patent B2
US 12,146,141 · App. 18/177,951 · Granted Nov 19, 2024

Compositions and methods for modifying genomes

Inventors: Matthew Begemann (St. Louis, MO); Benjamin Neil Gray (St. Louis, MO)
Assignee: RiceTec, Inc.
C12N15/82C12N9/22C12N15/102C12N15/8213C12N15/825C12N15/8269C07K14/415C07K2319/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,146,141
App. No.
18/177,951
Granted
Nov 19, 2024
Kind
B2
Abstract

Compositions and methods for modifying genomic DNA sequences are provided. The methods produce double-stranded breaks (DSBs) at pre-determined target sites in a genomic DNA sequence, resulting in mutation, insertion, and/or deletion of DNA sequences at the target site(s) in a genome. Compositions comprise DNA constructs comprising nucleotide sequences that encode a Cms1 protein operably linked to a promoter that is operable in the cells of interest. The DNA constructs can be used to direct the modification of genomic DNA at pre-determined genomic loci. Methods to use these DNA constructs to modify genomic DNA sequences are described herein. Additionally, compositions and methods for modulating the expression of genes are provided. Compositions comprise DNA constructs comprising a promoter that is operable in the cells of interest operably linked to nucleotide sequences that encode a mutated Cms1 protein with an abolished ability to produce DSBs, optionally linked to a domain that regulates transcriptional activity. The methods can be used to up- or down-regulate the expression of genes at predetermined genomic loci.

Claims (20)

1. A method of modifying a nucleotide sequence at a target site of a plant cell comprising:

introducing into said plant cell

(i) a guide RNA (gRNA), or a DNA polynucleotide encoding a gRNA, wherein the gRNA comprises: (a) a first segment comprising a nucleotide sequence that is complementary to the nucleotide sequence at the target site; and (b) a second segment that interacts with a Cms1 polypeptide; and

(ii) a Cms1 polypeptide, or a polynucleotide encoding a Cms1 polypeptide, wherein the Cms1 polypeptide comprises: (a) an RNA-binding portion that interacts with the gRNA; and (b) an activity portion that exhibits site-directed enzymatic activity,

wherein said Cms1 polypeptide has at least 95% sequence identity with the amino acid sequence set forth as any one of SEQ ID NOs: 11, 20-23, 30-69, and 222-254, and has endonuclease activity, wherein said method modifies said nucleotide sequence at said target site.

2. The method of claim 1 , further comprising:

culturing the plant cell to produce a plant under conditions in which the Cms1 polypeptide is expressed and cleaves the nucleotide sequence at the target site to produce a modified nucleotide sequence; and

selecting a plant comprising said modified nucleotide sequence.

3. The method of claim 1 , wherein said modified nucleotide sequence comprises insertion of heterologous DNA into the genome of the cell, deletion of a nucleotide sequence from the genome of the cell, or mutation of at least one nucleotide in the genome of the cell.

4. A nucleic acid molecule comprising a polynucleotide sequence encoding a Cms1 polypeptide, wherein said polynucleotide sequence has at least 95% sequence identity with the nucleotide sequence set forth as any one of SEQ ID NO: 16-19, 24-27, 70-126, 128-146, 174-176, and 255-287, or wherein said polynucleotide sequence encodes a Cms1 polypeptide with at least 95% sequence identity to the amino acid sequence set forth as any one of SEQ ID NOs: 20-23, 30-69, and 222-254, and has endonuclease activity, and wherein said polynucleotide sequence encoding a Cms1 polypeptide is operably linked to a promoter that is heterologous to the polynucleotide sequence encoding a Cms1 polypeptide.

5. The nucleic acid molecule of claim 4 , wherein said polynucleotide sequence encoding a Cms1 polypeptide comprises the nucleotide sequence set forth as any one of SEQ ID NO: 16-19, 24-27, 70-126, 128-146, 174-176, and 255-287, or encodes a Cms1 polypeptide that comprises the amino acid sequence set forth as any one of SEQ ID NOs: 20-23, 30-69, and 222-254.

6. A plant cell, eukaryotic cell, or prokaryotic cell comprising the nucleic acid molecule of claim 4 .

7. A plant cell, eukaryotic cell, or prokaryotic cell comprising the nucleic acid molecule of claim 5 .

8. A plant comprising the nucleic acid molecule of claim 4 .

9. A plant comprising the nucleic acid molecule of claim 5 .

10. The seed of the plant of claim 8 , wherein the seed comprises said nucleic acid molecule.

11. The method of claim 1 , wherein the method further comprises producing a plant from the plant cell, and wherein seed of the plant comprises said nucleic acid molecule.

12. The nucleic acid molecule of claim 4 wherein said polynucleotide sequence encoding a Cms1 polypeptide is codon-optimized for expression in a plant cell.

13. The method of claim 1 , wherein the gRNA is a DNA-targeting RNA.

14. The method of claim 1 , wherein the target site is in the genome of the plant cell, and wherein the genome is a nuclear, plastid, or mitochondrial genome.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 12, 2025
From: BENSON HILL, INC.; BENSON HILL HOLDINGS, INC.; BENSON HILL FRESH, LLC; BENSON HILL SEEDS HOLDING, INC.; BHB HOLDINGS, LLC; J&J SOUTHERN FARMS, INC.; BENSON HILL SEEDS, INC.
To: CONFLUENCE GENETICS, LLC
Reel/Frame 071578/0432 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 30, 2025
From: BENSON HILL, INC.; BENSON HILL HOLDINGS, INC.; BENSON HILL FRESH, LLC; BENSON HILL SEEDS HOLDING, INC.; BENSON HILL SEEDS, INC.; BHB HOLDINGS, LLC; J&J SOUTHERN FARMS, LLC
To: CONFLUENCE GENETICS, LLC
Reel/Frame 071982/0368 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 23, 2024
From: BEGEMANN, MATTHEW; GRAY, BENJAMIN NEIL
To: BENSON HILL BIOSYSTEMS, INC.
Reel/Frame 066548/0375 →
CHANGE OF NAME Recorded Feb 23, 2024
From: BENSON HILL, INC.
To: BENSON HILL HOLDINGS, INC.
Reel/Frame 066548/0668 →
CHANGE OF NAME Recorded Feb 23, 2024
From: BENSON HILL BIOSYSTEMS, INC.
To: BENSON HILL, INC.
Reel/Frame 066666/0055 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 8, 2023
From: BENSON HILL HOLDINGS, INC.
To: RICETEC, INC.
Reel/Frame 065500/0091 →
Continuity (8)
Division 17037040 · Sep 29, 2020
Continuation 16393062 · Apr 24, 2019
Division 16058718 · Aug 8, 2018
Provisional Application 62599226 · Dec 15, 2017
Provisional Application 62565255 · Sep 29, 2017
Provisional Application 62551958 · Aug 30, 2017
Provisional Application 62542983 · Aug 9, 2017
Related Publication 20230242925A1 · Aug 3, 2023